BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33991270)

  • 1. Electrolyte monitoring during regional citrate anticoagulation in continuous renal replacement therapy.
    Warnar C; Faber E; Katinakis PA; Schermer T; Spronk PE
    J Clin Monit Comput; 2022 Jun; 36(3):871-877. PubMed ID: 33991270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD).
    Mitchell A; Daul AE; Beiderlinden M; Schäfers RF; Heemann U; Kribben A; Peters J; Philipp T; Wenzel RR
    Clin Nephrol; 2003 Feb; 59(2):106-14. PubMed ID: 12608553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of regional citrate anticoagulation for continuous venovenous hemodialysis in critically ill cancer patients with acute kidney injury.
    Costa E Silva VT; Caires RA; Bezerra JS; Costalonga EC; Oliveira APL; Oliveira Coelho F; Fukushima JT; Soares CM; Oikawa L; Hajjar LA; Burdmann EA
    J Crit Care; 2018 Oct; 47():302-309. PubMed ID: 29859647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation.
    Khadzhynov D; Schelter C; Lieker I; Mika A; Staeck O; Neumayer HH; Peters H; Slowinski T
    J Crit Care; 2014 Apr; 29(2):265-71. PubMed ID: 24360392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study.
    Schultheiß C; Saugel B; Phillip V; Thies P; Noe S; Mayr U; Haller B; Einwächter H; Schmid RM; Huber W
    Crit Care; 2012 Aug; 16(4):R162. PubMed ID: 22913794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous hemodialysis with citrate anticoagulation and standard dialysate for managing acute kidney injury in patients with moderate to severe hyponatremia-A retrospective study.
    Hellman T; Uusalo P; Järvisalo MJ
    Acta Anaesthesiol Scand; 2021 Jul; 65(6):778-784. PubMed ID: 33595109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
    Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
    Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two regional citrate anticoagulation modalities for continuous renal replacement therapy by a prospective analysis of safety, workload, effectiveness, and cost.
    Cassina T; Villa M; Soldani-Agnello A; Zini P
    Minerva Anestesiol; 2021 Dec; 87(12):1309-1319. PubMed ID: 34527405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of regional citrate anticoagulation for continuous sustained low efficiency dialysis (C-SLED) in critically ill patients.
    Finkel KW; Foringer JR
    Ren Fail; 2005; 27(5):541-5. PubMed ID: 16152991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional Citrate Anticoagulation for Continuous Kidney Replacement Therapy With Calcium-Containing Solutions: A Cohort Study.
    Rhee H; Berenger B; Mehta RL; Macedo E
    Am J Kidney Dis; 2021 Oct; 78(4):550-559.e1. PubMed ID: 33798636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial.
    Zarbock A; Küllmar M; Kindgen-Milles D; Wempe C; Gerss J; Brandenburger T; Dimski T; Tyczynski B; Jahn M; Mülling N; Mehrländer M; Rosenberger P; Marx G; Simon TP; Jaschinski U; Deetjen P; Putensen C; Schewe JC; Kluge S; Jarczak D; Slowinski T; Bodenstein M; Meybohm P; Wirtz S; Moerer O; Kortgen A; Simon P; Bagshaw SM; Kellum JA; Meersch M;
    JAMA; 2020 Oct; 324(16):1629-1639. PubMed ID: 33095849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional citrate anticoagulation in continuous hemodialysis--acid-base and electrolyte balance at an increased dose of dialysis.
    Morgera S; Haase M; Ruckert M; Krieg H; Kastrup M; Krausch D; Vargas-Hein O; Zuckermann-Becker H; Peters H; Pohlmeier R; Neumayer HH
    Nephron Clin Pract; 2005; 101(4):c211-9. PubMed ID: 16155399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study.
    Slowinski T; Morgera S; Joannidis M; Henneberg T; Stocker R; Helset E; Andersson K; Wehner M; Kozik-Jaromin J; Brett S; Hasslacher J; Stover JF; Peters H; Neumayer HH; Kindgen-Milles D
    Crit Care; 2015 Sep; 19():349. PubMed ID: 26415638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexpected severe hypocalcemia during continuous venovenous hemodialysis with regional citrate anticoagulation.
    Meier-Kriesche HU; Finkel KW; Gitomer JJ; DuBose TD
    Am J Kidney Dis; 1999 Apr; 33(4):e8. PubMed ID: 10196039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: single-center experience.
    Morgera S; Scholle C; Voss G; Haase M; Vargas-Hein O; Krausch D; Melzer C; Rosseau S; Zuckermann-Becker H; Neumayer HH
    Nephron Clin Pract; 2004; 97(4):c131-6. PubMed ID: 15331942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive monitoring of post filter ionized calcium concentrations during CVVHD with regional citrate anticoagulation: A retrospective study.
    Khadzhynov D; Deissler J; Bobonov O; Schelter C; Peters H; Kindgen-Milles D; Budde K; Lehner LJ; Halleck F; Staeck O; Eckardt KU; Slowinski T
    J Crit Care; 2020 Aug; 58():1-5. PubMed ID: 32244094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement therapy in critically ill children.
    Sık G; Demirbuga A; Annayev A; Citak A
    Int J Artif Organs; 2020 Apr; 43(4):234-241. PubMed ID: 31856634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional citrate anticoagulation "non-shock" protocol with pre-calculated flow settings for patients with at least 6 L/hour liver citrate clearance.
    Yessayan L; Sohaney R; Puri V; Wagner B; Riddle A; Dickinson S; Napolitano L; Heung M; Humes D; Szamosfalvi B
    BMC Nephrol; 2021 Jul; 22(1):244. PubMed ID: 34215201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional citrate anticoagulation for continuous renal replacement therapy in the perioperative care of liver transplant recipients: a single center experience.
    Sponholz C; Settmacher U; Bauer M; Kortgen A
    Ther Apher Dial; 2015 Feb; 19(1):8-15. PubMed ID: 25196675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simplified regional citrate anticoagulation protocol for CVVH, CVVHDF and SLED focused on the prevention of KRT-related hypophosphatemia while optimizing acid-base balance.
    Di Mario F; Sabatino A; Regolisti G; Pacchiarini MC; Greco P; Maccari C; Vizzini G; Italiano C; Pistolesi V; Morabito S; Fiaccadori E
    Nephrol Dial Transplant; 2023 Sep; 38(10):2298-2309. PubMed ID: 37037771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.